Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL753P, formally named "RNA, 7SL, cytoplasmic 753, pseudogene", is a human pseudogene derived from the 7SL RNA, a critical RNA component of the signal recognition particle (SRP) involved in targeting secretory proteins to the endoplasmic reticulum[6][1]. Pseudogenes like RN7SL753P resemble functional genes but have lost the ability to encode functional RNA or proteins due to sequence mutations or truncations[6][5][7]. The 7SL pseudogene family results from retrotransposition events, producing truncated, nonfunctional copies scattered throughout the genome[5][7][3]. RN7SL753P itself does not produce a functional product and has no known role as a receptor, enzyme, transporter, or direct therapeutic target. However, in general, some pseudogenes can exert regulatory effects at the RNA level (e.g., through antisense or competing endogenous RNA activities), but there is no evidence for such a function described for RN7SL753P specifically[4]. Thus, RN7SL753P is officially cataloged as a processed pseudogene, lacking established biological or clinical relevance[6][1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 753, pseudogene (RN7SL753P).